Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion type Assertion NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_head.
- NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion description "[During active disease, patients with granulomatosis with polyangiitis (GPA; Wegener's granulomatosis) have accelerated atherosclerosis and ANGII inhibitors are recommended to these patients to reduce atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_provenance.
- NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion evidence source_evidence_literature NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_provenance.
- NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion SIO_000772 21936613 NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_provenance.
- NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion wasDerivedFrom befree-2016 NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_provenance.
- NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_assertion wasGeneratedBy ECO_0000203 NP925376.RATYh40-6rhb4LHs275XnkB1H6HdIzocHRhGnS7kq3bEA130_provenance.